Indian Journal of Clinical and Experimental Ophthalmology
Official Publication of Innovative Education and Scientific Research Foundation
Official Publication of Innovative Education and Scientific Research Foundation
Print ISSN: 2395-1443
Online ISSN: 2395-1451
CODEN : IJCEKF
Indian Journal of Clinical and Experimental Ophthalmology (IJCEO) is open access, a peer-reviewed medical journal, published quarterly, online, and in print, by the Innovative Education and Scientific Research Foundation (IESRF) since 2015. To fulfil our aim of rapid dissemination of knowledge, we publish articles ‘Ahead of Print’ on acceptance. In addition, the journal allows free access (Open Access) to its content, which is likely to attract more readers and citations of articles published in IJCEO. Manuscripts must be prepared in more...Review Article
Author Details :
Volume : 1, Issue : 4, Year : 2015
Article Page : 191-196
Abstract
Purpose of review: Review of the drug Rebamipide, an ophthalmic suspension, in the treatment of dry eye and other ocular surface disorders.
Method: An extensive literature search was done on articles published in various ophthalmic journals to review the work on the latest drug rebamipide and its role in treating dry eye and other ocular surface disorders.
Recent Findings: Rebamipide is a novel drug for the treatment of dry eye disorders. It is a mucin-secretogogue, has a cytoprotective, anti-inflammatory effect and also suppresses the detrimental oxygen free radicals and helps in faster healing of epithelium. No major side effect has been noticed apart from dysguesia.
Summary: Rebamipide is the latest drug introduced in the treatment of dry eye. It seems to be a safe and effective treatment in chronic and severe forms of dry eye particularly due to mucus deficiency.
Key Words: Dry eye, Goblet cell, Microvilli, Rebamipide, Tear film
How to cite : Dorennavar L, Maurya R P, Singh V P, Singh M K, Sharma K, Sharma R, The role of Rebamipide ophthalmic suspension in management of dry eye disease. Indian J Clin Exp Ophthalmol 2015;1(4):191-196
This is an Open Access (OA) journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.
